Foghorn presents preclinical data for cancer drug candidates at AACR

April 21, 2026 4:05 PM

Foghorn Therapeutics Inc. (NASDAQ: FHTX) presented preclinical data for multiple drug candidates at the 2026 American Association for Cancer Research ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found